References
- Gravett G. P., Buckmaster J. G., Watsom P. T., Gravett M., Elevated G. Second Trimester Maternal Serum β-hCG Concentrations and Subsequent Adverse Pregnancy Outcome. Am. J. Med. Genet. 1992; 44: 485–486
- Gonen R., Perez R., David M., Dar H., Merksamer R., Sharf M. The Association Between Unexplained Second-Trimester Maternal Serum hCG Elevation and Pregnancy Complications. Obstet. Gynecol. 1992; 80: 83–85
- Lieppman R. E., Williams M. A., Cheng E. Y., Resta R., Zingheim R., Hickok D. E., Luthy D. A. An Association Between Elevated Levels of Human Chorionic Gonadotropin in the Midtrimester and Adverse Pregnancy Outcome. Am. J. Obstet. Gynecol. 1993; 168: 1852–1857
- Luckas M. J., Sandland R., Hawe J., Neilson J. P., McFadyen I. R., Meekins J. W. Fetal Growth Retardation and Second Trimester Maternal Serum Human Chorionic Gonadotropin Levels. Placenta 1998; 19: 143–147
- Fox H., Path M. H. Effect of Hypoxia on Trophoblasts in Organ Culture, a Morphologic and Autoradiographic Study. Am. J. Obstet. Gynecol. 1970; 107: 1058–1064
- Strohmer H., Kiss H., Mosl B., Egarter C., Husslein P., Knofler M. Hypoxia Downregulates Continuous and Interleukin-1-Induced Expression of Human Chorionic Gonadotropin in Chorioncarcinoma Cells. Placenta 1997; 18: 597–604
- Esterman A., Finlay T. H., Dancis J. The Effect of Hypoxia on Term Trophoblast: Hormone Synthesis and Release. Placenta 1996; 17: 217–222
- Ezimokhai M., Mensah-Brown E. P., Agarwal M., Rizk D. E., Thomas L., Renal. Handling of Endogenous Human Chorionic Gonadotrophin in Pre-eclampsia. Hypertens Pregn. 1999; 18: 129–137
- Ashour A. M.N., Lieberman E. S., Haug L. E.W., Repke J. T. The Value of Elevated Second-Trimester β-Human Chorionic Gonadotropin in Predicting Development of Preeclampsia. Am. J. Obstet. Gynecol. 1997; 176: 438–442
- Moodley D., Moodley J., Buck R., Haneef R, Payne A. Free Alpha-Subunits of Human Chorionic Gonadotropin in Preeclampsia. Int. J. Obstet. Gynecol. 1995; 49: 283–287
- Sibai B. M., Mercer B., Sarinoglu C. Severe Pre-eclampsia in the Second Trimester: Recurrence Risk and Long-Term Prognosis. Am. J. Obstet. Gynecol. 1991; 165: 1408–1412
- Penttilä I. M., Ryynänen M., Hämäläinen E., Puhakainen E., Savolainen K., Quality. Specifications for S-AFP and S-hCG-Determinations for Screening of Fetal Abnormalities. Uppsala. Med. J. Sci. 1993; 98: 375–380
- Ribbert L. S., Kornman L. H., De Wolf B. T., Simons A. H.M., Jansen C. A.M., Beekhuis J. R., Mantingh A. Maternal Serum Screening for Fetal Down Syndrome in IVF Pregnancies. Prenat. Diagn. 1996; 16: 35–38
- Heinonen S., Ryynänen M., Kirkinen P., Saarikoski S. Elevated Midtrimester Maternal Serum hCG in Chromosomally Normal Pregnancies Is Associated with Preeclampsia and Velamentous Umbilical Cord Insertion. Am. J. Perinatol. 1996; 13: 437–441
- Walton D. L., Norem C. T., Schoen E. J., Ray G. T., Colby C. J. Second-Trimester Serum Chorionic Gonadotropin Concentrations and Complications and Outcome of Pregnancy. N. Engl. J. Med. 1999; 341: 2033–2038
- Heikkilä A., Heinonen S., Kirkinen P. Maternal Serum Second Trimester AFP and hCG in Pregnancies with Placenta Previa. Prenat. Diagn. 2000; 20: 100–102
- Yagel S., Geva T. E., Solomon H., Shimonovitz S., Reich R., Finci-Yeheskel Z., Mayer M., Milwidsky A. High Levels of Human Chorionic Gonadotropin Retard First Trimester Trophoblast Invasion In Vitro by Decreasing Urokinase Plasminogen Activator and Collagenase Activities. J. Clin. Endocrinol. Metab. 1993; 77: 1506–1511